NCT02469246 Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC Status COMPLETED Phase PHASE3
NCT02468557 Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma Status TERMINATED Phase PHASE1
NCT02466516 Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3 Status COMPLETED Phase PHASE2
NCT02457611 Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection Status COMPLETED Phase PHASE2
NCT02457598 Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies Status TERMINATED Phase PHASE1
NCT02457559 Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies Status COMPLETED Phase PHASE1
NCT02445131 Sequential Regimen of Bendamustine-Debulking Followed by CAL-101 and GA101-Induction and -Maintenance in CLL (CLL2-BCG) Status COMPLETED Phase PHASE2
NCT02441829 Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function Status COMPLETED Phase PHASE1
NCT02439138 Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia Status TERMINATED Phase PHASE2
NCT02436135 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Adults Receiving Ruxolitinib as Therapy for Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis With Progressive or Relapsed Disease Status TERMINATED Phase PHASE1
NCT02427204 Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality Status COMPLETED Phase N/A
NCT02423265 Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries Status WITHDRAWN Phase PHASE4
NCT02413593 Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection Status COMPLETED Phase PHASE2
NCT02412098 Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function Status COMPLETED Phase PHASE1
NCT02405442 Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease Status TERMINATED Phase PHASE2
NCT02404792 Exercise for Healthy Aging: The Impact of HIV and Aging on Physical Function and the Somatopause Status COMPLETED Phase NA
NCT02404220 Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) Status TERMINATED Phase PHASE1/PHASE2
NCT02402452 Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment Status COMPLETED Phase PHASE1
NCT02400307 Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function Status COMPLETED Phase PHASE1
NCT02397707 Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment Status COMPLETED Phase PHASE1